BCL2 Inhibitors Selectively Target Leukemia Stem Cells

Researchers from the University of Rochester have identified BCL2 inhibitors as potential leukemia stem cell-targeting agents, demonstrating that two such inhibitors killed inactive and metabolically slower leukemia stem cells.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news